{"slideshow_credits": null, "snippet": "Just hours after announcing its $8.4 billion acquisition of Cubist Pharmaceuticals, a Delaware judge invalidated patents owned by the antibiotics maker. Merck appears to have been caught up in the M.&.A. exuberance, says Robert Cyran of Reuters...", "abstract": "Just hours after announcing its $8.4 billion acquisition of Cubist Pharmaceuticals, a Delaware judge invalidated patents owned by the antibiotics maker. Merck appears to have been caught up in the M.&.A. exuberance, says Robert Cyran of Reuters Breakingviews.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "Robert", "role": "reported", "lastname": "CYRAN", "rank": 1, "organization": ""}], "original": "By ROBERT CYRAN"}, "web_url": "http://dealbook.nytimes.com/2014/12/09/mercks-rose-colored-deal-making/", "lead_paragraph": null, "headline": {"main": "Merck's Rose-Colored Glasses in Cubist Deal", "kicker": "DealBook"}, "_id": "54874e3538f0d8602128e04c", "word_count": "375", "multimedia": [{"height": 126, "url": "images/2014/12/10/business/dbpix-merck2/dbpix-merck2-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2014/12/10/business/dbpix-merck2/dbpix-merck2-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 400, "url": "images/2014/12/10/business/dbpix-merck2/dbpix-merck2-articleLarge.jpg", "legacy": {"xlarge": "images/2014/12/10/business/dbpix-merck2/dbpix-merck2-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2014/12/10/business/dbpix-merck2/dbpix-merck2-thumbStandard.jpg", "legacy": {"thumbnail": "images/2014/12/10/business/dbpix-merck2/dbpix-merck2-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2014-12-09T14:30:42Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Cubist Pharmaceuticals Inc", "name": "organizations", "rank": "1"}, {"value": "Food and Drug Administration", "name": "organizations", "rank": "2"}, {"value": "Merck & Company Inc", "name": "organizations", "rank": "3"}, {"value": "Antibiotics", "name": "subject", "rank": "1"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "2"}, {"value": "Inventions and Patents", "name": "subject", "rank": "3"}, {"value": "Mergers, Acquisitions and Divestitures", "name": "subject", "rank": "4"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}